Insider Selling: Plexus Corp. (NASDAQ:PLXS) CEO Sells 4,337 Shares of Stock

Plexus Corp. (NASDAQ:PLXS - Get Free Report) CEO Todd P. Kelsey sold 4,337 shares of the stock in a transaction on Wednesday, February 5th. The stock was sold at an average price of $142.23, for a total transaction of $616,851.51. Following the completion of the sale, the chief executive officer now directly owns 80,595 shares of the company's stock, valued at $11,463,026.85. The trade was a 5.11 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Plexus Stock Down 0.6 %

PLXS stock traded down $0.82 during midday trading on Friday, hitting $141.13. 194,588 shares of the company's stock were exchanged, compared to its average volume of 186,843. The firm has a 50 day moving average price of $158.56 and a 200-day moving average price of $144.08. Plexus Corp. has a 12-month low of $90.18 and a 12-month high of $172.89. The stock has a market capitalization of $3.82 billion, a price-to-earnings ratio of 32.74 and a beta of 0.89. The company has a current ratio of 1.53, a quick ratio of 0.70 and a debt-to-equity ratio of 0.07.

Plexus (NASDAQ:PLXS - Get Free Report) last posted its quarterly earnings results on Wednesday, January 22nd. The technology company reported $1.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.59 by ($0.10). Plexus had a net margin of 3.03% and a return on equity of 10.36%. On average, analysts anticipate that Plexus Corp. will post 5.94 EPS for the current year.

Institutional Trading of Plexus

Several hedge funds and other institutional investors have recently bought and sold shares of PLXS. Blue Trust Inc. grew its position in shares of Plexus by 12.1% in the 4th quarter. Blue Trust Inc. now owns 776 shares of the technology company's stock worth $121,000 after acquiring an additional 84 shares in the last quarter. Glenmede Trust Co. NA boosted its holdings in Plexus by 4.4% in the third quarter. Glenmede Trust Co. NA now owns 2,453 shares of the technology company's stock worth $335,000 after purchasing an additional 104 shares during the period. GAMMA Investing LLC increased its stake in Plexus by 17.2% during the fourth quarter. GAMMA Investing LLC now owns 891 shares of the technology company's stock valued at $139,000 after purchasing an additional 131 shares during the last quarter. Farrow Financial Inc. raised its holdings in shares of Plexus by 0.7% during the third quarter. Farrow Financial Inc. now owns 21,692 shares of the technology company's stock worth $2,966,000 after purchasing an additional 155 shares during the period. Finally, Quarry LP lifted its position in shares of Plexus by 573.5% in the 3rd quarter. Quarry LP now owns 229 shares of the technology company's stock worth $31,000 after buying an additional 195 shares during the last quarter. 94.45% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. KeyCorp assumed coverage on shares of Plexus in a research report on Tuesday, October 22nd. They set a "sector weight" rating for the company. Benchmark reaffirmed a "buy" rating and issued a $165.00 target price on shares of Plexus in a research report on Wednesday, January 22nd. StockNews.com upgraded Plexus from a "hold" rating to a "buy" rating in a report on Monday, November 18th. Needham & Company LLC upped their price target on Plexus from $162.00 to $172.00 and gave the stock a "buy" rating in a report on Friday, January 24th. Finally, Stifel Nicolaus assumed coverage on shares of Plexus in a research note on Tuesday, February 4th. They set a "hold" rating and a $152.00 price objective on the stock. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $163.00.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.